CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Buy Walgreens (WBA) Stock on Expanded Kroger (KR) Partnership?
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) touched a new 52-week high Tuesday morning as investors began to digest the possibilities of what its partnership with grocery power Kroger (KR) might do to boost traffic as it expands its reach in the quickly changing retail age.
Should You Buy Kroger (KR) Stock Before Q3 Earnings?
by Benjamin Rains
Let's see what to expect from Kroger to understand if KR stock might be worth buying.
CVS Health Closes Aetna Deal, Focuses More on Pharmacy Wing
by Zacks Equity Research
The joint entity of CVS Health (CVS) and Aetna will provide customers with the powerful health resources of the former and the latter's network of providers for quality care.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $80.27, moving +0.97% from the previous trading session.
Company News For Nov 27, 2018
by Zacks Equity Research
Companies In The News Are: ZFGN,CLF,AET,CVS,GWPH
CVS Health (CVS) Gets Final Approval to Close Aetna Deal
by Zacks Equity Research
Both CVS Health (CVS) and Aetna are hopeful about this consolidation, which is aimed at revolutionizing consumer health care experience and substantial cost reduction.
4 Stocks to Buy as US Labor Market Reaches Full Potential
by Zacks Equity Research
An overly tight labor market could push wages up further, increasing consumer optimism around spending.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $75.07, marking a -0.6% move from the previous day.
Near-Term Outlook for Health Maintenance Organization Industry
by Zacks Equity Research
Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $80.34 in the latest trading session, marking a +0.64% move from the prior day.
CVS Health's (CVS) Q3 Earnings Top Estimate, Gross Margin Up
by Zacks Equity Research
CVS Health's (CVS) year-over-year growth in the top line was driven by a strong Pharmacy Services segment, benefiting from the upside in the specialty services.
Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR
by Ryan McQueeney
Ryan McQueeney chats with Dave Bartosiak about the near-term outlook for stocks after the midterm elections and the earnings outlook for Turtle Beach ahead of its report. The host also recaps earnings results from CVS, Eli Lilly, and Regeneron.
Stocks Gain Ahead of Midterm Results, But Where Are They Headed Next?
by Ryan McQueeney
U.S. stocks opened modestly higher on Tuesday, as investors kept a watchful eye on the historically tense midterm elections. Here's what market strategists are saying will happen after the midterms.
September JOLTS Report In Spotlight
by Zacks Equity Research
September JOLTS Report In Spotlight
Playing the Waiting Game; Plus MedTech, Pharma in Q3 Earnings
by Mark Vickery
We won't get the final numbers until later, so until then we're just playing the waiting game.
CVS Health (CVS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What to Expect from CVS Health's Q3 Earnings
by Benjamin Rains
Let's see what to expect from CVS before the opening bell Tuesday.
Should You Buy CVS Stock Ahead of Q3 Earnings?
by Benjamin Rains
Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.
Upcoming Earnings Reports to Watch: CVS, QCOM, DIS
by Ryan McQueeney
Stocks were down in morning trading Friday, putting major indexes on track to snap a three-day winning streak that followed a brutal month of selling. But will next week's earnings results get the rebound back on track? Let's take a closer look at a few of the earnings announcements due during the week of November 5!
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $72.84, moving +0.61% from the previous trading session.
Will CVS Health's (CVS) PBM Strength Boost Q3 Earnings?
by Zacks Equity Research
Despite a challenging pricing scenario, CVS Health (CVS) is currently gaining on high level of service and execution as well as a competitive pricing along with unique integrated model.
Aetna (AET) Q3 Earnings Beat Estimates, Membership Increases
by Zacks Equity Research
Aetna (AET) earnings grow on revenue and membership gains.
CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $70.67, moving +1.23% from the previous trading session.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $73.72 in the latest trading session, marking a +0.9% move from the prior day.